Palatin Technologies
PTN
#9923
Rank
A$59.27 M
Marketcap
A$34.81
Share price
4.59%
Change (1 day)
2,314.53%
Change (1 year)

Palatin Technologies (PTN) - Net assets

Net assets on the balance sheet as of March 2025 : -A$9.67 Million

According to Palatin Technologies's latest financial reports the company has -A$9.67 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Palatin Technologies - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$-A$0.17 Million-94.38%
2023-06-30$-A$2.98 Million-112.6%
2022-06-30$A$23.58 M-64.39%
2021-06-30$A$66.22 M-42.99%
2020-06-30$A$0.11 B-18.86%
2019-06-30$A$0.14 B293.05%
2018-06-30$A$36.42 M-641.48%
2017-06-30$-A$6.73 Million-71.51%
2016-06-30$-A$23.61 Million-248.84%
2015-06-30$A$15.86 M52.8%
2014-06-30$A$10.38 M-58.76%
2013-06-30$A$25.17 M1308.07%
2012-06-30$A$1.78 M-89.47%
2011-06-30$A$16.97 M54.28%
2010-06-30$A$11 M168.59%
2009-06-30$A$4.09 M-40.21%
2008-06-30$A$6.85 M-68.7%
2007-06-30$A$21.88 M-11.54%
2006-06-30$A$24.74 M104.63%
2005-06-30$A$12.08 M-56.93%
2004-06-30$A$28.07 M0.48%
2003-06-30$A$27.93 M80.52%
2002-06-30$A$15.47 M-33.54%
2001-06-30$A$23.28 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
MediciNova
MNOV
A$70.92 M-833.62%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A$5.1 M-152.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$4.54 B-47,126.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.76 B-8,019.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.43 B-14,976.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$120.00 B-1,241,304.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.23 B-2,515.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$69.58 B-719,847.62%๐Ÿ‡ฌ๐Ÿ‡ง UK